We use cookies to improve your experience. By continuing to browse this site, you accept our cookie policy.×
Skip main navigation
Aging Health
Bioelectronics in Medicine
Biomarkers in Medicine
Breast Cancer Management
CNS Oncology
Colorectal Cancer
Concussion
Epigenomics
Future Cardiology
Future Medicine AI
Future Microbiology
Future Neurology
Future Oncology
Future Rare Diseases
Future Virology
Hepatic Oncology
HIV Therapy
Immunotherapy
International Journal of Endocrine Oncology
International Journal of Hematologic Oncology
Journal of 3D Printing in Medicine
Lung Cancer Management
Melanoma Management
Nanomedicine
Neurodegenerative Disease Management
Pain Management
Pediatric Health
Personalized Medicine
Pharmacogenomics
Regenerative Medicine
Published Online:https://doi.org/10.2217/14622416.7.3.467

Study population: We examined the relationship between chronic fatigue syndrome (CFS) and allostatic load in a population-based, case–control study of 43 CFS patients and 60 nonfatigued, healthy controls from Wichita, KS, USA. Methods: An allostatic load index was computed for all study participants using available laboratory and clinical data, according to a standard algorithm for allostatic load. Logistic regression analysis was used to compute odds ratios (ORs) as estimates of relative risk in models that included adjustment for matching factors and education; 95% confidence intervals (CIs) were computed to estimate the precision of the ORs. Results: CFS patients were 1.9-times more likely to have a high allostatic load index than controls (95% CI = 0.75, 4.75) after adjusting for education level, in addition to matching factors. The strength of this association increased in a linear trend across categories of low, medium and high levels of allostatic load (p = 0.06). Conclusion: CFS was associated with a high level of allostatic load. The three allostatic load components that best discriminated cases from controls were waist:hip ratio, aldosterone and urinary cortisol.

Papers of special note have been highlighted as of interest (•) to readers.

Bibliography

  • Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A and the International Chronic Fatigue Syndrome Study Group: The chronic fatigue syndrome: a comprehensive approach to its definition and study. Ann. Intern. Med.1211, 953–959 (1994).
  • Reeves WC, Wagner D, Nisenbaum R et al.: Chronic fatigue syndrome – a clinically empirical approach to its definition and study. BMC Med. 3, 19 (2005).
  • Ito Y, Wakai K, Suzuki K et al.: Lung cancer mortality and serum levels of carotenoids, retinol, tocopherols, and folic acid in men and women: a case–control study nested in the JACC Study. J. Epidemiol.15(Suppl. 2), S140–S149 (2005).
  • Shulze MB, Hoffman K, Manson JE et al.: Dietary pattern, inflammation, and incidence of type 2 diabetes in women. Am. J. Clin. Nutr.82, 675–684 (2005).
  • Buijsse B, Feskens EJM, Schlettwien-Gsell D et al. for the SENECA investigators: Plasma carotene and α-tocopherol in relation to 10-y all-cause and cause-specific mortality in European elderly: the Survey in Europe on Nutrition and the Elderly, a Concerted Action (SENECA). Am. J. Clin. Nutr.82, 879–886 (2005).
  • Albert CM, Oh K, Whang W et al.: Dietary α-linolenic acid intake and risk of sudden cardiac death and coronary heart disease. Circulation112, 3232–3238 (2005).
  • Schieken RM, Clarke WR, Lauer RM: Left ventricular hypertrophy in children with blood pressures in the upper quintile of the distribution. The Muscatine Study. Hypertension3, 669–675 (1981).
  • Granel B, Serratrice J, Schleinitz N et al.: Diagnostic approach to hypereosinophilia. Med. Trop. (Mars)58, 489–492 (1998).
  • Gartner R, Gasnier BC, Dietrich JW et al.: Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase concentrations. J. Clin. Endocrinol. Metab.87, 1687–1691 (2002).
  • 10  Sterling P, Eyer J: Allostasis: a new paradigm to explain arousal pathology. In: Handbook of Life Stress, Cognition and Health. Fisher S & Reason J (Ed.), John Wiley & Sons, New York, NY, USA, 629–649 (1988).
  • 11  McEwen BS, Stellar E: Stress and the individual. Mechanisms leading to disease. Arch. Intern. Med.153, 2093–2101 (1993).
  • 12  McEwen BS, Seeman, T: Protective and damaging effects of mediators of stress: elaborating and testing the concepts of allostasis and allostatic load. Ann. NY Acad. Sci.896, 30–47 (1999).• Described central roles of the hypothalmic–pituitary–adrenal (HPA) axis and the sympathetic nervous system in the allostatic load construct, based on the regulatory role of stress hormones produced by these systems in response to physiological demands.
  • 13  Karlamangla AS, Singer BH, McEwen BS, Rowe JW, Seeman TE: Allostatic load is a predictor of functional decline: MacArthur studies of successful aging. J. Clin. Epidemiol.55, 696–710 (2002).
  • 14  Seeman TE, McEwen BS, Rowe JW, Singer BH: Allostatic load as a marker of cumulative biological risk: MacArthur Studies of Successful Aging. Proc. Natl Acad. Sci. USA98, 4770–4775 (2001).• Analyzed a prospective study of 70–79 year olds that measured health outcomes over a 7-year period and detected significant risks for mortality and decline in physical and cognitive functioning associated with elevated allostatic load at baseline.
  • 15  Seeman TE, Singer BH, Rowe JW, Horwitz RI, McEwen BS: Price of adaptation-allostatic load and its health consequences. Arch.Intern. Med.157, 2259–2268 (1997).
  • 16  Roberts A, Wessely S, Chalder T, Papadopoulos A, Cleare AJ: Salivary cortisol response to awakening in chronic fatigue syndrome. British J. Psychiatry184, 136–141 (2004).
  • 17  Demitrack MA, Crofford LJ: Evidence for and pathophysiologic implications of hypothalamic–pituitary–adrenal axis dysregulation in fibromyalgia and chronic fatigue syndrome. Ann. NY Acad. Sci.840, 684–697 (1998).
  • 18  Vernon SD, Reeves WC: The challenge of integrating disparate high-content data: epidemiological, clinical, and laboratory data collected during an in-hospital study of chronic fatigue syndrome. Pharmacogenomics7(3), 345–354 (2006).
  • 19  Gurbaxani BM, Jones JF, Goertzel BN, Maloney EM: Linear data mining the Wichita clinical matrix suggests sleep and allostatic load involvement in chronic fatigue syndrome. Pharmacogenomics7(3), 455–465 (2006).
  • 20  Forsey RJ, Thompson JM, Emerudh J et al.: Plasma cytokine profiles in elderly humans. Mech. Ageing Dev.124, 487–493 (2003).
  • 21  Karlamangla AS, Singer BH, Chodosh J, McEwen BS, Seeman TE: Urinary cortisol excretion as a predictor of incident cognitive impairment. Neurobiology of Aging (In press) (2005).
  • 22  Goertzel BN, Pennachin C, Coelho Lds, Maloney EM, Jones JF, Gurbaxani B: Allostatic load is associated with symptoms in chronic fatigue syndrome patients. Pharmacogenomics7(3), (2006).
  • 23  Wilson PWF, Nam B-H, Pencina M, D'Agostine RB, Benjamin EJ, O'Donnell CJ: C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Hearth Study. Arch. Intern. Med.165, 2473–2478 (2005).
  • 24  Rashid S, Lewis GF: The mechanisms of differential glucocorticoid and mineralocorticoid action in the brain and peripheral tissues. Clin. Biochem.38, 401–409 (2005).
  • 25  Torpy DJ, Bachmann AW, Grice JE et al.: Familial corticosteroid-binding globulin deficiency due to a novel null mutation: association with fatigue and relative hypotension. J. Clin. Endocrinol. Metab.86, 3692–3700 (2001).
  • 26  Peters A, Schweiger U, Pellerin L et al.: The selfish brain: competition for energy resources. Neurosci. Biobehav. Rev.28, 143–180 (2004).